•57 patients are in ICU, out of which 18 are on ventilatory support.
•Another, 86 patients are separately on supplementary oxygen, out of which 68 are in general wards and 18 in the HDU.
Kenya's Covid-19 fatalities have another all-time high for the second day in a row after 26 people succumbed to the virus.
This brings the total fatalities to 1,180.
Health CS Mutahi Kagwe on Wednesday confirmed that 1,216 new cases of the virus were reported from a sample size of 6,816.
This is a positivity rate of 17.8 per cent.
This brings the number of cases in the country to 65,804 since March, while the cumulative tests stand at 760,775.
Kagwe said that there are 1,289 patients currently admitted in various hospitals across the country.
Another, 5,960 patients are in the home-based care programme.
A total of 57 patients are in ICU, out of which 18 are on ventilatory support.
Also, 86 patients are separately on supplementary oxygen, out of which 68 are in general wards and 18 in the HDU.
At least 2,148 healthcare workers have contracted the virus since it's index case in Kenya. Out of this, 1,087 are males and 1,061 are female workers.
Twenty-three healthcare workers have lost their lives since the pandemic struck.
From the new cases reported on Wednesday, 1,174 are Kenyans while 42 are foreigners.
In terms of gender, 726 are males while 490 are females and the youngest in an eleven -month-old infant and the oldest is 99.
Nairobi leads with 439 cases, Mombasa 250, Kilifi 63, Kaimbu 59, Taita Taveta 52, Nyeri 41, Uasin Gishu 38, Laikipia 32, Kisumu 30, Kajiado 24, Kakamega 24 an Kitui 22.
Siaya 20, Machakos 19, Bungoma 17, Meru 14, Nandi 11, Tana River 10, Garissa 9, Homabay 8, Kisii 8, Nakuru 6, Kirinyaga 5, Murang'a 3 and Elgeyo Marakwet 2.
Turkana, Nyandarua, Nyamira, Trans Nzoia, Kwale, Migori, West Pokot and Makuen recorded single cases each.
Meanwhile, Kagwe has expressed reservations concerning the Pfizer-developed Covid-19 vaccine.
The Pfizer-BioNTech vaccine, has been found to be 90 per cent effective in preventing Covid-19.
The manufacturer is among more than 25 drug makers who have expressed interest to supply developing countries with the vaccine under the Sh300-per-dose plan led by the World Health Organization.
But speaking on Wednesday when he appeared before the Senate Health Committee, Kagwe said there is no excitement about the vaccine.
"Yes we are hearing that there is a vaccine. I have got my many doubts.. we are talking about a vaccine that stops someone from getting the virus," he said.
"I would like to know how they knew that I was going to get the virus so that they give me the vaccine. When you tell me that you stopped me from getting the virus how will you know that you stopped me?"